Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Anemia, Hemolytic, Autoimmune

fingolimod hydrochloride has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Davani, DN; Ghajarzadeh, M; Najdaghi, S; Shaygannejad, V1
Benghiat, F; Lysandropoulos, AP1

Reviews

1 review(s) available for fingolimod hydrochloride and Anemia, Hemolytic, Autoimmune

ArticleYear
Autoimmune hemolytic anemia after treatment with fingolimod in a patient with multiple sclerosis (MS): A case report and review of the literature.
    Autoimmunity reviews, 2022, Volume: 21, Issue:12

    Topics: Anemia, Hemolytic, Autoimmune; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting

2022

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Anemia, Hemolytic, Autoimmune

ArticleYear
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2013, Volume: 19, Issue:11

    Topics: Anemia, Hemolytic, Autoimmune; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Sphingosine; Young Adult

2013